RE: New write up on OBD10 Oct 2023 14:02
"The company has created a now very valuable technology portfolio, including biomarker arrays, molecular diagnostic tests, bioinformatic tools for 3D genomics and an expertly curated 3D genome knowledgebase comprising hundreds of millions of data points from over 15,000 samples in more than 30 human diseases."
So many potential strings to OBDs bow :)